Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

Condition:   Head and Neck Squamous Cell Carcinoma Intervention:   Drug: Carrilizumab, bevacizumab,capecitabine Sponsor:   Second Affiliated Hospital of Guangzhou Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials